Bryce Point Capital LLC bought a new position in Veeva Systems Inc. (NYSE:VEEV – Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 2,905 shares of the technology company’s stock, valued at approximately $837,000.
Several other hedge funds and other institutional investors have also recently bought and sold shares of VEEV. Abound Financial LLC bought a new position in Veeva Systems in the first quarter worth $25,000. Trust Co. of Toledo NA OH bought a new position in shares of Veeva Systems during the second quarter valued at $29,000. Wayfinding Financial LLC bought a new position in shares of Veeva Systems during the first quarter valued at $32,000. Legacy Investment Solutions LLC bought a new position in shares of Veeva Systems during the second quarter valued at $32,000. Finally, Maseco LLP bought a new position in shares of Veeva Systems during the second quarter valued at $35,000. 88.20% of the stock is owned by institutional investors.
Veeva Systems Stock Performance
Shares of NYSE:VEEV opened at $292.69 on Tuesday. Veeva Systems Inc. has a twelve month low of $201.54 and a twelve month high of $310.50. The firm has a market cap of $47.97 billion, a PE ratio of 60.10, a price-to-earnings-growth ratio of 2.22 and a beta of 0.98. The business has a fifty day moving average of $285.36 and a 200-day moving average of $273.45.
Analysts Set New Price Targets
A number of brokerages have issued reports on VEEV. Stifel Nicolaus lifted their price objective on Veeva Systems from $295.00 to $320.00 and gave the company a “buy” rating in a report on Thursday, August 28th. Barclays lifted their price objective on Veeva Systems from $300.00 to $325.00 and gave the company an “overweight” rating in a report on Thursday, August 28th. Truist Financial lifted their price objective on Veeva Systems from $268.00 to $275.00 and gave the company a “hold” rating in a report on Thursday, August 28th. KeyCorp lifted their price objective on Veeva Systems from $285.00 to $325.00 and gave the company an “overweight” rating in a report on Monday, July 14th. Finally, Mizuho raised their target price on Veeva Systems from $295.00 to $325.00 and gave the company an “outperform” rating in a research note on Friday, August 29th. Seventeen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, Veeva Systems presently has a consensus rating of “Moderate Buy” and a consensus target price of $307.58.
Read Our Latest Research Report on VEEV
Insider Buying and Selling
In related news, SVP Jonathan Faddis sold 720 shares of Veeva Systems stock in a transaction dated Monday, October 6th. The stock was sold at an average price of $298.12, for a total value of $214,646.40. Following the completion of the sale, the senior vice president directly owned 7,868 shares in the company, valued at $2,345,608.16. This trade represents a 8.38% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Thomas D. Schwenger sold 3,350 shares of Veeva Systems stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $300.04, for a total value of $1,005,134.00. Following the completion of the sale, the insider owned 23,773 shares of the company’s stock, valued at approximately $7,132,850.92. The trade was a 12.35% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 24,665 shares of company stock worth $7,438,000 over the last three months. 10.30% of the stock is currently owned by company insiders.
Veeva Systems Profile
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
Further Reading
- Five stocks we like better than Veeva Systems
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Semiconductor Supercycle: Why Onsemi Stock Could Double as AI and EV Growth Accelerate
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- The Best Local Butchers for Thanksgiving [2025 Survey]
- Do ETFs Pay Dividends? What You Need to Know
- $134M in Insider Moves: What It Might Mean for KMI, ISRG and QS
Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV – Free Report).
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
